68-3

98/130

) Ogawa H, Kurebayashi N, Yamazawa T, Murayama T: Regulatory mechanisms of ryan-odine receptor/Ca2+ release channel revealed by recent advancements in structural studies, J Muscle Res Cell Motil, 2020; doi: 10.1007/s10974-020-09575-6.) Okubo Y, Iino M: Visualization of astrocytic intracellular Ca2+ mobilization. J Physiol, 2020; 598: 1671-1681.) Okubo Y: Astrocytic Ca2+ signaling mediated by the endoplasmic reticulum in health and disease. J Pharmacol Sci, 2020; 144: 83-88.) Mizukoshi K, Okazawa Y, Haeno H, Koyama Y, Sulidan K, Komiyama H, Saeki H, Ohtsuji N, Ito Y, Kojima Y, Goto M, Habu S, Hino O, Sakamoto K,* Orimo A*: Metastatic seeding of human colon cancer cell clusters expressing the hybrid epithelial/mesenchymal state. International Journal of Cancer, 2020; 146: 2547-2562. doi: 10.1002/ijc.32672 ) Blanco-Gómez A, Hontecillas-Prieto L, Corcha-do-Cobos R, García-Sancha N, Salvador N, Castellanos-Martín A, Sáez-Freire MDM, Mendiburu-Eliçabe M, Alonso-López D, De Las Rivas J, Lorente M, García-Casas A, Del Carmen S, Abad-Hernández MDM, Cruz-Hernández JJ, Rodríguez-Sánchez CA, Claros- Ampuero J, Carcía-Cenador B, García-Criado J, Orimo A, Gridley T, Pérez-Losada J, Castil-lo-Lluva S: Stromal SNAI2 is required for ERBB2 breast cancer progression. Cancer 294skeletal RyR mutations at an equivalent site by cryo-EM. Sci Adv, 2020; 6: eabb2964.† 12) Ma R, Haji-Ghassemi O, Ma D, Jiang H, Lin L, Yao L, Samurkas A, Li Y, Wang Y, Cao P, Wu S, Zhang Y, Murayama T, Moussian B, Van Petegem F, Yuchi Z: Structural basis for diamide modulation of ryanodine receptor. Nat Chem Biol, 2020; 16: 1246-1254. 13) Zi Li, Murakoshi M, Ichikawa S, Koshida T, Adachi E, Suzuki C, Ueda S, Gohda T, Suzuki Y: The sodium-glucose cotransporter 2 inhib-itor tofogliflozin prevents diabetic kidney disease progression in type 2 diabetic mice. FEBS Open Bio, 2020; 10: 2761-2770.〈Reviews〉 1 2 3Molecular Pathogenesis〈Original Articles〉 1 2Res, 2020. doi: 10.1158/0008-5472.＊ 3) Yanai Y, Saito T, Hayashi T, Akazawa Y, Yatagai N, Tsuyama S, Tomita S, Hirai S, Ogura K, Matsumoto T, Wada R, Yao T: Molecular and clinicopathological features of appendiceal mucinous neoplasms. Virchows Arch, 2020.† 4) Han B, Lee-Okada H-C, Ishimine M, Orita H, Nishikawa K, Takagaki T, Kajino K, Yokomizo T, Hino O, Kobayashi T: Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells. FEBS Open Bio, 2020; 10: 2375-2387. https://doi.org/10. 1002/2211-5463.12985＊ 5) Inoue T, Kokubo T, Daino K, Yanagihara H, Watanabe F, Tsuruoka C, Amasaki, Y, Morioka T, Homma-Takeda S, Kobayashi T, Hino O, Shimada Y, Kakinuma S: Interstitial chromosomal deletion of the Tsc2 locus is a signature for radiation-associated renal tumors in Eker rats. Cancer Sci, 2020; 111: 840-848.) Yamashita K, Mizuno K, Furukawa K, Hirose H, Sakurai N, Masuda-Hirata M, Amano Y, Hirose T, Suzuki A, Ohno S: Phosphorylation and dephosphorylation of Ser852 and Ser889 control the clustering, localization and func-tion of PAR3. Journal of Cell Science, 2020; 133: jcs244830.) Matsumura E, Kajino K, Abe M, Ohtsuji N, Saeki H, Hlaing M.T, Hino O: Expression status of PD-L1 and B7-H3 in mesothelioma. Pathology International, 2020; 70: 999-1008. doi：10.1111/pin.13028. Epub 2020 Oct 7.) Kojima M, Kajino K, Momose S, Wali N, Thinzar Hlaing M, Han B, Yue L, Abe M, Fujii T, Ikeda K, Hino O: Possible revers-ibility between epithelioid and sarcomatoid types of mesothelioma is independent of ERC/ mesothelin expression. Respiratory Research, 2020; 21: 187. doi: 10.1186/s12931-020-01449-2) Smith RM, Jones RB, RITAZAREM coinves-tigators, Hmano Y. et al: Rituximab as therapy to induce remission after relapse in ANCA-as-sociated vasculitis. Ann Rheum Dis, 2020; 79: 1243-1249. doi:10.1136/annrheumdis-2019- 216863. Epub 2020 Jun 24. PMID: 32581088; PMCID:PMC7456549. 6 7 8 9 10) Walsh M, Merkel PA, PEXIVAS Investiga-tors. et al: Plasma Exchange and Glucocorti-